ST Segment Yükselmeli Miyokard İnfarktüsü ile Başvuran Hastalarda Hastane İçi ve Uzun Dönem Mortalitenin Değerlendirilmesi: Üçüncü Basamak Kardiyoloji Merkezi Deneyimi

Amaç: İskemik kalp hastalığı tüm dünyada önde gelen bir ölüm sebebidir ve kardiyovasküler hastalığı olan hastalarda yaşam beklentisini uzatmak için sadece sağlık hizmeti sağlayıcılarının stratejileri değil, toplum özellikleri de önem arz etmektedir. Bu nedenle, ilgilenilen toplum özelliklerini yansıtan, ulusal, klinik çalışmalar gerçek yaşam sağlık hizmetleri hakkında önemli bilgiler vermektedir. Biz bu çalışma ile üçüncü basamak kardiyoloji merkezimize başvuran ST elevasyonlu miyokart enfarktüsü (STEMI) hastalarında hastane içi ve uzun dönem sonuçlarımızı değerlendirmeyi amaçladık. Gereç ve Yöntemler: Primer perkütan koroner girişim (PCI) ile tedavi edilen ve telefon ile yaptığımız sorgulamalara cevap veren veya takiplerinde vefat ettiği belgelenen toplam 178 STEMI hastası analizlere dâhil edildi. Bu hastalar yaşa göre üç gruba ayrıldı (Grup-1:

Evaluation of Intra-hospital and Long-term Mortality in Patients Presenting with ST-segment Elevation Myocardial Infarction: A Tertiary Cardiology Center Experience

Objective: Ischemic heart disease remains the leading cause of death. Not only strategies of health care providers but also population characteristics are also important to extend life expectancy in patients with cardiovascular disease. Thus clinical studies including national cohort of patients provide important insights into the real-life health care. We aimed to assess intra-hospital and long-term outcomes in patients with ST-elevation myocardial infarction (STEMI). Materials and Methods: A total of 178 STEMI patients treated with primary percutaneous coronary intervention (PCI), who were documented to be death or responded the telephone interview, were included into the analyses. These patients were divided into three groups according to age (Group-1:

___

  • 1. Szummer K, Wallentin L, Lindhagen L, Alfredsson J, Erlinge D, Held C, et al.Improved outcomes in patients with ST-elevation myocardial infarction during the last 20 years are related to implementation of evidence-based treatments: experiences from the SWEDEHEART registry 1995-2014. Eur Heart J 2017;38:3056-3065.
  • 2. World Health Organization, Top 10 causes of death. http://www9.who.int/gho/mortality_burden_disease/causes_death/top_10/en/
  • 3. Fervers B, Burgers JS, Haugh MC, Latreille J, Mlika-Cabanne N, Paquet L, et al. Adaptation of clinical guidelines: literature review and proposition for a framework and procedure. Int J Qual Health Care 2006;18:167-76.
  • 4. Ui S, Chino M, Isshiki T. Rates of primary percutaneous coronary intervention worldwide. Circ J 2005 ;69:95-100.
  • 5. The Lancet. 40 years of percutaneous coronary intervention: where next? Lancet 2017;390:715.
  • 6. Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH), European Heart Journal 2018 ; 39,3021–3104.
  • 7. Cosentino F, Grant PJ, Aboyans V, Bailey CJ, Ceriello A, Delgado V, et al. 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: The Task Force for diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and the European Association for the Study of Diabetes (EASD), European Heart Journal 2020; 41,255–323.
  • 8. Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Coresh J, Rossert J, et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2005; 67: 2089-100.
  • 9. Schuijf JD, Wijns W, Jukema JW, Atsma DE, de Roos A, Lamb HJ, Stokkel MP, et al. Relationship between noninvasive coronary angiography with multi-slice computed tomography and myocardial perfusion imaging. J Am Coll Cardiol 2006; 48 :2508-14.
  • 10. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18, 499-502.
  • 11. Townsend N, Wilson L, Bhatnagar P, Wickramasinghe K, Rayner M, Nichols M. Cardiovascular disease in Europe: epidemiological update 2016. Eur Heart J 2016;37: 3232–3245.
  • 12. Puymirat E, Simon T, Steg PG, Schiele F, Guéret P, Blanchard D, et al. FAST MI Investigators. Association of changes in clinical characteristics and management with improvement in survival among patients with ST-elevation myocardial infarction. JAMA 2012; 308: 998–1006.
  • 13. Kristensen SD, Laut KG, Fajadet J, Kaifoszova Z, Kala P, Di Mario, et al. European Association for Percutaneous Cardiovascular Interventions. Reperfusion therapy for ST elevation acute myocardial infarction 2010/2011: current status in 37 ESC countries. Eur Heart J 2014;35:1957–1970.
  • 14. Yao H, Ekou A, Hadéou A, N’Djessan JJ, Kouamé I, N’Guetta R. Medium and long-term follow-up after ST-segment elevation myocardial infarction in a sub-Saharan Africa population: a prospective cohort study. BMC Cardiovasc Disord 2019;19: 65.
  • 15. Agarwal SK, Singla I, Hreybe H, Saba S. Clinical predictors of late death in survivors of acute myocardial infarction. Tex Heart Inst J 2009; 36 :24-30.
  • 16. Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 2018; 39 : 119-177.
  • 17. Zorbozan O, Cevik AA, Acar N, Ozakin N, Ozcelik H, Birdane A, et al. Predictors of mortality in ST-elevation MI patients: A prospective study. Medicine (Baltimore) 2018; 97: e0065.
  • 18. Hannan EL, Zhong Y, Jacobs AK, Holmes DR, Walford G, Venditti FJ, et al. Effect of onset-to-door time and door to-balloon time on mortality in patients undergoing percutaneous coronary interventions for ST-segment elevation myocardial infarction. Am J Cardiol. 2010;106:143–7.
  • 19. Budzianowski J, Pieszko K, Burchardt P, Rzeźniczak J, Hiczkiewicz J. The Role of Hematological Indices in Patients with Acute Coronary Syndrome. Dis Markers 2017;2017:3041565.
  • 20. Ensrud K, Grimm RH Jr. The white blood cell count and risk for coronary heart disease. Am Heart J 1992 ;124:207-13
  • 21. Yarnell JW, Baker IA, Sweetnam PM, Bainton D, O'Brien JR, Whitehead PJ, et al. Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The Caerphilly and Speedwell collaborative heart disease studies. Circulation 1991;83:836-44.
  • 22. Grau AJ, Boddy AW, Dukovic DA, Buggle F, Lichy C, Brandt T, et al; CAPRIE Investigators. Leukocyte count as an independent predictor of recurrent ischemic events. Stroke 2004;35:1147-52.
  • 23. Huczek Z, Kochman J, Filipiak KJ, Horszczaruk GJ, Grabowski M, Piatkowski R, et al. Mean platelet volume on admission predicts impaired reperfusion and long-term mortality in acute myocardial infarction treated with primary percutaneous coronary intervention. J Am Coll Cardiol 2005 ;46:284-90.
Sakarya Tıp Dergisi-Cover
  • Başlangıç: 2011
  • Yayıncı: Sakarya Üniversitesi
Sayıdaki Diğer Makaleler

Çocuk ve Ergen Psikiyatrisi Polikliniğine Başvuran Hastaların Tanı Dağılımı ve Tedavilerinin Değerlendirilmesi

Şenay KILINÇEL

Frenchay Aktiviteler İndeksinin Türkçe Versiyonunun Psikometrik Özelliklerinin Değerlendirmesi ile Kültürel Adaptasyonu

Nuray ALACA

Travmatik Pnömotorakslı 127 Hastanın Değerlendirilmesi: Tek Merkez Deneyimi

Kerim TÜLÜCE, Gürkan ALTUNTAŞ

Ameliyathane Dışı Anestezi(ADA) Uygulanan Endobronşial Ultrasonografi (EBUS) İşlemlerinde Premedikasyon İlaçlarının Entegre Pulmoner İndeks Skoruna Etkisi

Leyla KAZANCIOĞLU, Hizir KAZDAL

ST Segment Yükselmeli Miyokard İnfarktüsü Hastalarında Koroner Arter Hastalığının Ciddiyeti ile Serum Adropin Seviyesi Arasındaki İlişkinin Değerlendirilmesi

Mustafa ÖZTÜRK, Oguzhan Ekrem TURAN, Engin ŞEBİN, Gökhan CEYHUN, Emrah AKSAKAL, Kamuran KALKAN, Oktay GULCU, Ali KORKMAZ, Murat BAYANTEMUR

Serebral Palsili Çocuklarda Adaptif Cihaz Kullanımını Etkileyen Faktörler

Mehmet KURTARAN

ST Segment Yükselmeli Miyokard İnfarktüsü ile Başvuran Hastalarda Hastane İçi ve Uzun Dönem Mortalitenin Değerlendirilmesi: Üçüncü Basamak Kardiyoloji Merkezi Deneyimi

Göktuğ SAVAŞ, Mehmet KIZILAY, Melek SÜZER

Otoimmün Hepatit Hastalarında Karaciğer Fibrozisi ile Ortalama Trombosit Hacmi Arasındaki Korelasyon

Mehmet Nur KAYA, Ali KIRIK, Mehmet İÇLİ, Ayla YILDIZ, Ömer TOPRAK

Covid-19 Pozitif Gebede Acil Sezaryen Anestezisi Yönetimi: Olgu Sunumu

Bedirhan GÜNEL, Fatih ŞAHİN, Ayça TAŞ TUNA

Preterm ve Term Yenidoğanlarda İlk Banyo Zamanlarının ve Farklı Banyo Yöntemlerinin Termoregülasyona Etkisi: Sistematik Derleme

Atiye KARAKUL, Pınar DOĞAN